Quick Answer
Sanara MedTech Inc. reported R&D Expense of $5.07 million for fiscal year 2025.
Sanara MedTech Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $5.07M | +79.3% |
| 2024 | $2.83M | -31.5% |
| 2023 | $4.13M | +22.7% |
| 2022 | $3.37M | +502.7% |
| 2021 | $558.7K | +1290.2% |
| 2020 | $40.2K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.03M | +31.4% | -18.1% |
| June 30, 2025 | $1.26M | +27.6% | +12.9% |
| March 31, 2025 | $1.11M | +17.7% | +42.1% |
| September 30, 2024 | $783.8K | -20.5% | -20.5% |
| June 30, 2024 | $985.7K | -16.3% | +4.2% |
| March 31, 2024 | $946.3K | -28.2% | -4.1% |
| September 30, 2023 | $986.5K | -7.1% | -16.2% |
| June 30, 2023 | $1.18M | +10.3% | -10.6% |
- Sanara MedTech Inc. showed an increase of +79.3% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, Sanara MedTech Inc.’s r&d expense has grown by 12521.3% (from $40.2 thousand to $5.07 million).
- The most recent figure is from Sanara MedTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: